These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10387954)

  • 61. Release kinetics and immunogenicity of parvovirus microencapsulated in PLA/PLGA microspheres.
    Pálinkó-Biró E; Rónaszèki G; Merkle HP; Gander B
    Int J Pharm; 2001 Jun; 221(1-2):153-7. PubMed ID: 11397576
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres.
    Benelli P; Conti B; Genta I; Costantini M; Montanari L
    J Microencapsul; 1998; 15(4):431-43. PubMed ID: 9651865
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics and biodistribution of paclitaxel-loaded microspheres.
    Yan F; Tang S; Fu Q
    Arzneimittelforschung; 2012 Apr; 62(4):176-80. PubMed ID: 22270845
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S; Janoria KG; Mitra AK
    J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
    Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
    Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PLGA microspheres for oral osteopenia treatment: preliminary "in vitro"/"in vivo" evaluation.
    Perugini P; Genta I; Conti B; Modena T; Cocchi D; Zaffe D; Pavanetto F
    Int J Pharm; 2003 Apr; 256(1-2):153-60. PubMed ID: 12695021
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
    Duggirala SS; Mehta RC; DeLuca PP
    Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.
    Marinina J; Shenderova A; Mallery SR; Schwendeman SP
    Pharm Res; 2000 Jun; 17(6):677-83. PubMed ID: 10955840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sustained bronchodilation with isoproterenol poly(glycolide-co-lactide) microspheres.
    Lai YL; Mehta RC; Thacker AA; Yoo SD; McNamara PJ; DeLuca PP
    Pharm Res; 1993 Jan; 10(1):119-25. PubMed ID: 8430048
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
    Lu L; Stamatas GN; Mikos AG
    J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
    Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles.
    Shenderova A; Burke TG; Schwendeman SP
    Pharm Res; 1997 Oct; 14(10):1406-14. PubMed ID: 9358554
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Preparation and evaluation of poly (D, L-lactic acid) (PLA) or D, L-lactide/glycolide copolymer (PLGA) microspheres with estradiol.
    Xinteng Z; Weisan P; Ruhua Z; Feng Z
    Pharmazie; 2002 Oct; 57(10):695-7. PubMed ID: 12426951
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide.
    Zhang Y; Wischke C; Mittal S; Mitra A; Schwendeman SP
    Mol Pharm; 2016 Aug; 13(8):2622-30. PubMed ID: 27144450
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Poly(lactide-co-glycolide) microspheres containing bupivacaine: comparison between gamma and beta irradiation effects.
    Montanari L; Cilurzo F; Selmin F; Conti B; Genta I; Poletti G; Orsini F; Valvo L
    J Control Release; 2003 Jul; 90(3):281-90. PubMed ID: 12880695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis.
    Murillo M; Gamazo C; Goñi MM; Irache JM; Blanco-Príeto MJ
    Int J Pharm; 2002 Aug; 242(1-2):341-4. PubMed ID: 12176275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
    Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
    Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.